Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07525427) titled 'Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis' on April 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Gates Medical Research Institute
Condition:
Drug Susceptible Pulmonary Tuberculosis
Intervention:
Drug: Bedaquiline, pretomanid and TBD09
Drug: Bedaquiline, pretomanid and TBD09
Drug: Bedaquiline, pretomanid and TBD09
Drug: Bedaquiline, pretomanid and TBD09
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollmen...